PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

LinkedIn

Stewardship Cuts Carbapenem Use in Surgical Wards

Infectious Disease / Antimicrobials

Background Information

Carbapenem stewardship in surgical wards could curb rising resistance.

High carbapenem use in surgical wards drives antimicrobial resistance, requiring strategic interventions to optimize antibiotic stewardship. The study aims to measure changes in carbapenem use and resistance patterns due to a multimodal intervention across surgical wards. This study provides prospective data supporting multimodal stewardship interventions, addressing a gap typically filled by retrospective studies or single-component programs. Multimodal stewardship interventions may reduce carbapenem use and resistance in surgical wards, enhancing patient safety.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Subscribe for Full Access →

Authors: Vazquez-Piqueras N, Padullés A, Sabé N, Shaw E, Abelenda-Alonso G, Suárez-Lledó A, Costa RM, Peláez N, Molina Molina GJ, Dordal MT, Andres B, Jiménez-Martínez E, Laguna MDM, Peñafiel J, Carratalà J, Oriol I

Citation: Vazquez-Piqueras N, Padullés A, Sabé N, et al. Effect of a multimodal intervention in general and digestive surgery wards on carbapenem use and antimicrobial resistance: protocol for a prospective, quasi-experimental interrupted time-series study. BMJ open. 2026;16(6):e118013. doi:10.1136/bmjopen-2026-118013

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Full deep analysis for this article is still in progress. Check back soon.